Volume 27, Number 7—July 2021
Synopsis
Transboundary Spread of Brucella canis through Import of Infected Dogs, the Netherlands, November 2016–December 2018
Table 1
Notification no. | Notifyingparty | Reason for notification | Clinical diagnosis or complaint | Serologic results (NRL) | Tracking investigation |
Case ID | |
---|---|---|---|---|---|---|---|
Litter (positive/tested/ identified), littermates | Contact dogs (positive/tested/identified) | ||||||
1 | VMDC | B. canis positive culture | Discospondylitis | >1:400 | NA | 0/1/1 | 1 |
2 | VMDC | Clinical complaint | Epididymitis | ˂1:50 | NA | NA | |
3 | VMDC | Clinical complaint | Discospondylitis | >1:400 | Litter 1 (2/2/2), 2 littermates | NA | 2, 3–4 |
4 | VP | Clinical complaint | Discospondylitis | >1:400 | Litter 2 (5/5/8), 5 littermates | NA | 5, 6–10 |
5 | NRL | Seropositive | Discospondylitis | 1:200 | NA | 0/3/5 | 11 |
6 | VP | Clinical complaint | Discospondylitis | 1:100 | NA | NA | |
7 | NRL | Seropositive | Discospondylitis | >1:400 | NA | 1 (inconclusive)/2/3 | 12 |
8 | NRL | Seropositive | Neck pain | 1:100 | NA | NA | |
9 | NRL | Seropositive | Back pain | >1:400 | Litter 3 (1/1/1), 1 littermate | 0/0/2 | 13, 14 |
10 | NRL | Seropositive | Behavioral problem | >1:400 | NA | 0/0/2 | 15 |
11 | NRL | Seropositive | Discospondylitis | >1:400 | NA | NA | 16 |
12 | VP | Clinical complaint | Lameness | ˂1:50 | NA | NA | |
13 | VMDC | B. canis positive culture | Lameness | >1:400 | NA | NA | 17 |
14 | VP | Clinical complaint | Lameness | ˂1:50 | NA | NA | |
15 | VP | Clinical complaint | Epididymitis | ˂1:50 | NA | NA | |
16 | NRL | Seropositive | Discospondylitis | >1:400 | NA | NA | 18 |
*ID, identification; NA, not applicable; NRL, National Reference Laboratory; VMDC, Veterinary Microbiological Diagnostic Center, Utrecht University; VP, veterinary practitioner.
1These senior authors contributed equally to this article.
Page created: May 17, 2021
Page updated: June 16, 2021
Page reviewed: June 16, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.